Get the Stockscreener App
1.5972
2.38%
0.0372
Geovax Labs Inc stock is traded at $1.5972, with a volume of 34,771.
It is up +2.38% in the last 24 hours and down -39.27% over the past month.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
See More
Previous Close:
$1.56
Open:
$1.61
24h Volume:
34,771
Relative Volume:
0.23
Market Cap:
$3.54M
Revenue:
$6.14M
Net Income/Loss:
$-24.81M
P/E Ratio:
-0.6414
EPS:
-2.49
Net Cash Flow:
$-27.40M
1W Performance:
-0.18%
1M Performance:
-39.27%
6M Performance:
-91.44%
1Y Performance:
-95.77%
1-Day Range:
$1.49
$1.61
1-Week Range:
$1.49
$1.69
52-Week Range:
$1.26
$47.12
Geovax Labs Inc Stock (GOVX) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678-384-7220
Address
1900 LAKE PARK DRIVE, SMYRNA
Compare GOVX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
1.59 | 3.47M | 6.14M | -24.81M | -27.40M | -2.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.11 | 123.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.03 | 83.60B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
751.44 | 46.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.04 | 43.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
294.20 | 34.79B | 4.98B | 69.60M | 525.67M | 0.5198 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Downgrade | D. Boral Capital | Buy → Hold |
| Apr-15-25 | Reiterated | Alliance Global Partners | Buy |
| Apr-15-25 | Reiterated | D. Boral Capital | Buy |
| Nov-11-24 | Initiated | Alliance Global Partners | Buy |
| Jul-16-24 | Initiated | ROTH MKM | Buy |
| Nov-19-20 | Initiated | Maxim Group | Buy |
View All
Geovax Labs Inc Stock (GOVX) Latest News
Performance Recap: What is the long term forecast for GeoVax Labs Inc Equity Warrant stockJuly 2025 EndofMonth & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Insider Trends: Will GeoVax Labs Inc benefit from geopolitical trendsJuly 2025 Action & Risk Controlled Swing Alerts - baoquankhu1.vn
GOVX PE Ratio & Valuation, Is GOVX Overvalued - Intellectia AI
GOVX Should I Buy - Intellectia AI
GOVX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Hedge Fund Bets: What is Cross Country Healthcare Incs valuation compared to sectorGap Up & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Treasury Yields: Is GeoVax Labs Inc Equity Warrant a strong candidate for buy and holdInsider Buying & Advanced Technical Analysis Signals - baoquankhu1.vn
GeoVax Forms Oncology Advisory Board to Guide Gedeptin Development in Solid Tumors - citybuzz -
GeoVax Announces Oncology Advisory Board to Advance Gedeptin(R) Development Across Solid Tumors - Yahoo Finance
Aug Final Week: Does GeoVax Labs Inc Equity Warrant align with a passive investing strategy2025 Fundamental Recap & Community Verified Trade Alerts - baoquankhu1.vn
GOVX Stock Price, Forecast & Analysis | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
Bull Bear: What is the long term forecast for GeoVax Labs Inc Equity Warrant stockTake Profit & Weekly Return Optimization Alerts - baoquankhu1.vn
GeoVax Labs downgraded to Hold from Buy at D. Boral Capital - TipRanks
D. Boral Capital downgrades GeoVax Labs stock rating to Hold - Investing.com Nigeria
D. Boral Capital downgrades GeoVax Labs stock rating to Hold By Investing.com - Investing.com South Africa
Geovax Labs (GOVX) Receives Downgrade to 'Hold' by D. Boral Capi - GuruFocus
GeoVax Expands Immuno-Oncology Portfolio with Exclusive License for Gedeptin Combination Technology - citybuzz -
GeoVax Expands Immuno-Oncology Strategy with Exclusive License for Gedeptin Combination Technology - citybuzz -
GeoVax Secures Exclusive License for Gedeptin(R) + Immune Checkpoint Inhibitor Combination Technology - Yahoo Finance
Dow Update: Will GeoVax Labs Inc outperform the market in YEARJuly 2025 Setups & Reliable Breakout Forecasts - baoquankhu1.vn
GeoVax Labs Announces Financing Through Equity Offerings - TipRanks
GeoVax Raises ~$0.87M at $2.31 in Registered Direct Offering, Adds Private Warrants - TradingView
GeoVax Endorses Global Call for Sustained Mpox Response, Highlights Vaccine Program Readiness - citybuzz -
GeoVax Endorses Global Call to Sustain Mpox Response as Evidence Confirms Epidemic Is Far From Over - TradingView
GeoVax Labs Inc. (NASDAQ:GOVX) Short Interest Update - Defense World
What is GeoVax Labs Inc.’s valuation compared to sectorJuly 2025 Breakouts & Real-Time Volume Spike Alerts - mfd.ru
GeoVax Labs Secures $1 Million in Direct Offering to Advance Clinical Programs - citybuzz -
GeoVax Labs Announces $1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - TradingView
What is the long term forecast for GeoVax Labs Inc. Equity Warrant stockQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - mfd.ru
Analyst Calls: What is GeoVax Labs Incs valuation compared to sectorJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - baoquankhu1.vn
Sentiment Review: What is GeoVax Labs Incs valuation compared to sectorPortfolio Gains Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Will GeoVax Labs Inc. benefit from geopolitical trendsEarnings Recap Report & Risk Managed Investment Strategies - mfd.ru
Aug Swings: Will GeoVax Labs Inc outperform the market in YEARProfit Target & Long-Term Safe Investment Plans - baoquankhu1.vn
Valuation Update: Why is BLIV stock going downJuly 2025 Reactions & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Can GeoVax Labs Inc. Equity Warrant outperform under higher oil pricesShare Buyback & Trade Opportunity Analysis - mfd.ru
Can GeoVax Labs Inc. Equity Warrant expand into new markets2025 Dividend Review & Precise Swing Trade Alerts - mfd.ru
Does GeoVax Labs Inc. Equity Warrant align with a passive investing strategyEarnings Summary Report & Weekly Setup with High ROI Potential - mfd.ru
Aug Levels: Does GeoVax Labs Inc Equity Warrant align with a passive investing strategyWeekly Investment Summary & Smart Swing Trading Alerts - baoquankhu1.vn
S P Trends: How cyclical is GeoVax Labs Inc Equity Warrants revenue streamShare Buyback & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Value Recap: What is the long term forecast for GeoVax Labs Inc. Equity Warrant stockPortfolio Update Summary & Weekly Sector Rotation Insights - baoquankhu1.vn
GeoVax Labs announces public equity offering for liquidity - MSN
Geovax Labs (GOVX) Receives "Buy" Rating Again from D. Boral Cap - GuruFocus
Aug Macro: What is GeoVax Labs Incs revenue forecastEarnings Miss & AI Optimized Trading Strategy Guides - baoquankhu1.vn
GeoVax Identifies 2026 as Critical Year for Vaccine Development and Commercialization - citybuzz -
GeoVax Highlights 2026 as a Pivotal Year for Progress - Yahoo Finance
Published on: 2026-01-19 17:25:09 - baoquankhu1.vn
Sentiment Review: What analysts say about CHRW stock2025 Volatility Report & Fast Moving Trade Plans - baoquankhu1.vn
Moving Averages: What is Delek US Holdings Incs valuation compared to sectorQuarterly Portfolio Summary & Growth Focused Entry Point Reports - baoquankhu1.vn
Insider Sell: How much upside does GeoVax Labs Inc Equity Warrant have2025 Valuation Update & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
GeoVax Labs (GOVX) Price Target Increased by 2,400.00% to 237.15 - Nasdaq
Weekly Recap: How cyclical is GeoVax Labs Inc Equity Warrants revenue stream2025 Major Catalysts & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Geovax Labs Inc Stock (GOVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.19%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):